Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Grishchenko MV, Lushchekina SV, Astakhova TY, Serebryakova OG, Timokhina EN, Zhilina EF, Shchegolkov EV, Ulitko MV, Radchenko EV, Palyulin VA, Burgart YV, Saloutin VI, Bachurin SO, Richardson RJ (2023) <br />Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease<br /><i>Int J Mol Sci</i> <b>24</b>: 2285<br /><br />Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Timokhina EN, Serebryakova OG, Shchepochkin AV, Averkov MA, Utepova IA, Demina NS, Radchenko EV, Palyulin VA, Fisenko VP, Bachurin SO, Chupakhin ON, Charushin VN, Richardson RJ (2023) <br />Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit beta-amyloid self-aggregation: potential therapeutic agents for Alzheimer's disease<br /><i>Front Pharmacol</i> <b>14</b>: 1219980<br /><br />Bachurin SO, Shevtsova EF, Makhaeva GF, Aksinenko AY, Grigoriev VV, Goreva TV, Epishina TA, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Vinogradova DV, Shevtsov PN, Pushkareva EA, Dubova LG, Serkova TP, Veselov IM, Fisenko VP, Richardson RJ (2022) <br />Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease<br /><i>Int J Mol Sci</i> <b>23</b>: <br /><br />Elkina NA, Grishchenko MV, Shchegolkov EV, Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Astakhova TY, Radchenko EV, Palyulin VA, Zhilina EF, Perminova AN, Lapshin LS, Burgart YV, Saloutin VI, Richardson RJ (2022) <br />New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones<br /><i>Biomolecules</i> <b>12</b>: <br /><br />Grishchenko MV, Makhaeva GF, Burgart YV, Rudakova EV, Boltneva NP, Kovaleva NV, Serebryakova OG, Lushchekina SV, Astakhova TY, Zhilina EF, Shchegolkov EV, Richardson RJ, Saloutin VI (2022) <br />Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease<br /><i>ChemMedChem</i> <br /><br />Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ (2022) <br />Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile<br /><i>Molecules</i> <b>27</b>: <br /><br />Semenov VE, Zueva IV, Lushchekina SV, Suleimanov EG, Gubaidullina LM, Shulaeva MM, Lenina OA, Petrov KA (2022) <br />Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease<br /><i>Molecules</i> <b>27</b>: <br /><br />Bachurin SO, Makhaeva GF, Shevtsova EF, Aksinenko AY, Grigoriev VV, Shevtsov PN, Goreva TV, Epishina TA, Kovaleva NV, Pushkareva EA, Boltneva NP, Lushchekina SV, Gabrelyan AV, Zamoyski VL, Dubova LG, Rudakova EV, Fisenko VP, Bovina EV, Richardson RJ (2021) <br />Conjugation of Aminoadamantane and gamma-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands<br /><i>Molecules</i> <b>26</b>: <br /><br />Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Kovaleva NV, Rudakova EV, Elkina NA, Shchegolkov EV, Burgart YV, Stupina TS, Terentiev AA, Radchenko EV, Palyulin VA, Saloutin VI, Bachurin SO, Richardson RJ (2021) <br />Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold<br /><i>Eur Journal of Medicinal Chemistry</i> <b>218</b>: 113385<br /><br />Makhaeva GF, Lushchekina SV, Kovaleva NV, Yu Astakhova T, Boltneva NP, Rudakova EV, Serebryakova OG, Proshin AN, Serkov IV, Trofimova TP, Tafeenko VA, Radchenko EV, Palyulin VA, Fisenko VP, Korabecny J, Soukup O, Richardson RJ (2021) <br />Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment<br /><i>Bioorg Chem</i> <b>112</b>: 104974<br /><br />Mukhametgalieva AR, Lushchekina SV, Aglyamova AR, Masson P (2021) <br />Steady-state kinetic analysis of human cholinesterases over wide concentration ranges of competing substrates<br /><i>Biochimica & Biophysica Acta Proteins Proteom</i> <br /><br />Akimov MG, Kudryavtsev DS, Kryukova EV, Fomina-Ageeva EV, Zakharov SS, Gretskaya NM, Zinchenko GN, Serkov IV, Makhaeva GF, Boltneva NP, Kovaleva NV, Serebryakova OG, Lushchekina SV, Palikov VA, Palikova Y, Dyachenko IA, Kasheverov IE, Tsetlin VI, Bezuglov VV (2020) <br />Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System<br /><i>Biomolecules</i> <b>10</b>: <br /><br />Burilova EA, Pashirova TN, Zueva IV, Gibadullina EM, Lushchekina SV, Sapunova AS, Kayumova RM, Rogov AM, Evtjugin VG, Sudakov IA, Vyshtakalyuk AB, Voloshina AD, Bukharov SV, Burilov AR, Petrov KA, Zakharova LY, Sinyashin OG (2020) <br />Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route<br /><i>Nanoscale</i> <b>12</b>: 13757<br /><br />Lushchekina SV, Masson P (2020) <br />Slow-binding inhibitors of acetylcholinesterase of medical interest<br /><i>Neuropharmacology</i> <br /><br />Lushchekina SV, Inidjel G, Martinez N, Masson P, Trovaslet-Leroy M, Nachon F, Koza MM, Seydel T, Peters J (2020) <br />Impact of Sucrose as Osmolyte on Molecular Dynamics of Mouse Acetylcholinesterase<br /><i>Biomolecules</i> <b>10</b>: <br /><br />Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Astakhova TY, Rudakova EV, Proshin AN, Serkov IV, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ (2020) <br />New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment<br /><i>Molecules</i> <b>25</b>: 3915<br /><br />Makhaeva GF, Kovaleva NV, Rudakova EV, Boltneva NP, Lushchekina SV, Faingold, II, Poletaeva DA, Soldatova YV, Kotelnikova RA, Serkov IV, Ustinov AK, Proshin AN, Radchenko EV, Palyulin VA, Richardson RJ (2020) <br />New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer's Disease Treatment<br /><i>Molecules</i> <b>25</b>: 5891<br /><br />Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Petukhova EO, Gubaidullina LM, Krylova ES, Saifina LF, Lenina OA, Petrov KA (2020) <br />Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease<br /><i>Molecules</i> <b>25</b>: <br /><br />Zueva IV, Lushchekina SV, Daude D, Chabriere E, Masson P (2020) <br />Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry<br /><i>Molecules</i> <b>25</b>: <br /><br />Zueva IV, Lushchekina SV, Pottie IR, Darvesh S, Masson P (2020) <br />1-(3-Tert-Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies<br /><i>Biomolecules</i> <b>10</b>: <br /><br />Bachurin SO, Makhaeva GF, Shevtsova EF, Boltneva NP, Kovaleva NV, Lushchekina SV, Rudakova EV, Dubova LG, Vinogradova DV, Sokolov VB, Aksinenko AY, Fisenko VP, Richardson RJ, Aliev G (2019) <br />Conjugates of methylene blue with gamma-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases<br /><i>Sci Rep</i> <b>9</b>: 4873<br /><br />Grigorenko BL, Novichkova DA, Lushchekina SV, Zueva IV, Schopfer LM, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P (2019) <br />Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad<br /><i>Chemico-Biological Interactions</i> <b>306</b>: 138<br /><br />Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI (2019) <br />Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers<br /><i>Bioorganic & Medicinal Chemistry Lett</i> <br /><br />Makhaeva GF, Elkina NA, Shchegolkov EV, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Radchenko EV, Palyulin VA, Burgart YV, Saloutin VI, Bachurin SO, Richardson RJ (2019) <br />Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors<br /><i>Bioorg Chem</i> <b>91</b>: 103097<br /><br />Makhaeva GF, Shevtsova EF, Boltneva NP, Lushchekina SV, Kovaleva NV, Rudakova EV, Bachurin SO, Richardson RJ (2019) <br />Overview of novel multifunctional agents based on conjugates of gamma-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease<br /><i>Chemico-Biological Interactions</i> <b>308</b>: 224<br /><br />Makhaeva GF, Rudakova EV, Kovaleva NV, Lushchekina SV, Boltneva NP, Proshin AN, Shchegolkov EV, Burgart YV, Saloutin VI (2019) <br />Cholinesterase and carboxylesterase inhibitors as pharmacological agents<br /><i>Russ Chem Bull</i> <b>68</b>: 967<br /><br />Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Radchenko EV, Palyulin VV, Bachurin SO, Richardson RJ (2019) <br />Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation<br /><i>Bioorg Chem</i> <br /><br />Mukhametgalieva AR, Zueva IV, Aglyamova AR, Lushchekina SV, Masson P (2019) <br />A new sensitive spectrofluorimetric method for measurement of activity and kinetic study of cholinesterases<br /><i>Biochimica & Biophysica Acta Proteins Proteom</i> <br /><br />Mukhametgalieva AR, Aglyamova AR, Lushchekina SV, Golicnik M, Masson P (2019) <br />Time-course of human cholinesterases-catalyzed competing substrate kinetics<br /><i>Chemico-Biological Interactions</i> <b>310</b>: 108702<br /><br />Novichkova DA, Lushchekina SV, Dym O, Masson P, Silman I, Sussman JL (2019) <br />The four-helix bundle in cholinesterase dimers: Structural and energetic determinants of stability<br /><i>Chemico-Biological Interactions</i> <b>309</b>: 108699<br /><br />Padnya PL, Bayarashov EE, Zueva IV, Lushchekina SV, Lenina OA, Evtugyn VG, Osin YN, Petrov KA, Stoikov, II (2019) <br />Water-soluble betaines and amines based on thiacalix[4]arene scaffold as new cholinesterase inhibitors<br /><i>Bioorg Chem</i> <br /><br />Semenov VE, Zueva IV, Lushchekina SV, Lenina OA, Gubaidullina LM, Saifina LF, Shulaeva MM, Kayumova RM, Saifina AF, Gubaidullin AT, Kondrashova SA, Latypov SK, Masson P, Petrov KA (2019) <br />6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: Reactivation for paraoxon-inhibited acetylcholinesterase<br /><i>Eur Journal of Medicinal Chemistry</i> <b>185</b>: 111787<br /><br />Zueva IV, Dias J, Lushchekina SV, Semenov VE, Mukhamedyarov MA, Pashirova TN, Babaev VM, Nachon F, Petrova N, Nurullin LF, Zakharova LY, Ilyin VI, Masson P, Petrov KA (2019) <br />New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease<br /><i>Neuropharmacology</i> <b>155</b>: 131<br /><br />Boyko KM, Baymukhametov TN, Chesnokov YM, Hons M, Lushchekina SV, Konarev PV, Lipkin AV, Vasiliev AL, Masson P, Popov VO, Kovalchuk MV (2018) <br />3D structure of the natural tetrameric form of human butyrylcholinesterase as revealed by cryoEM, SAXS and MD<br /><i>Biochimie</i> <b>156</b>: 196<br /><br />Lushchekina SV, Schopfer LM, Grigorenko BL, Nemukhin AV, Varfolomeev SD, Lockridge O, Masson P (2018) <br />Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents<br /><i>Front Pharmacol</i> <b>9</b>: 211<br /><br />Makhaeva GF, Kovaleva NV, Lushchekina SV, Rudakova EV, Boltneva NP, Proshin AN, Lednev BV, Serkov IV, Bachurin SO (2018) <br />Conjugates of Tacrine and Its Cyclic Homologues with p-Toluenesulfonamide as Novel Acetylcholinesterase and Butyrylcholinesterase Inhibitors<br /><i>Dokl Biochem Biophys</i> <b>483</b>: 369<br /><br />Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ (2018) <br />Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics<br /><i>Bioorganic & Medicinal Chemistry</i> <b>26</b>: 4716<br /><br />Petrov KA, Zueva IV, Kovyazina IV, Sedov I, Lushchekina SV, Kharlamova AD, Lenina O, Koshkin S, Shtyrlin Y, Nikolsky EE, Masson P (2018) <br />C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies<br /><i>Neuropharmacology</i> <b>131</b>: 304<br /><br />Zueva IV, Lushchekina SV, Masson P (2018) <br />Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase<br /><i>Bioscience Reports</i> <b>38</b>: <br /><br />Bachurin SO, Shevtsova EF, Makhaeva GF, Grigoriev VV, Boltneva NP, Kovaleva NV, Lushchekina SV, Shevtsov PN, Neganova ME, Redkozubova OM, Bovina EV, Gabrelyan AV, Fisenko VP, Sokolov VB, Aksinenko AY, Echeverria V, Barreto GE, Aliev G (2017) <br />Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment<br /><i>Sci Rep</i> <b>7</b>: 45627<br /><br />Dafferner AJ, Lushchekina SV, Masson P, Xiao G, Schopfer LM, Lockridge O (2017) <br />Characterization of butyrylcholinesterase in bovine serum<br /><i>Chemico-Biological Interactions</i> <b>266</b>: 17<br /><br />Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ (2017) <br />9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment<br /><i>Bioorganic & Medicinal Chemistry</i> <b>25</b>: 5981<br /><br />Shchegol'kov EV, Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Burgart YV, Saloutin VI, Chupakhin ON, Bachurin SO, Richardson RJ (2017) <br />Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors<br /><i>Bioorganic & Medicinal Chemistry</i> <b>25</b>: 3997<br /><br />Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, Zueva IV, Krejci E, Reznik VS, Zobov VV, Nikolsky EE, Masson P (2016) <br />Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment<br /><i>Biochemical Journal</i> <b>473</b>: 1225<br /><br />Lushchekina SV, Nemukhin AV, Varfolomeev SD, Masson P (2016) <br />Understanding the non-catalytic behavior of human butyrylcholinesterase silent variants: comparison of wild-type enzyme, catalytically active Ala328Cys mutant, and silent Ala328Asp variant<br /><i>Chemico-Biological Interactions</i> <b>259</b>: 223<br /><br />Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ (2016) <br />Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors<br /><i>Bioorganic & Medicinal Chemistry</i> <b>24</b>: 1050<br /><br />Makhaeva GF, Rudakova EV, Serebryakova OG, Aksinenko AY, Lushchekina SV, Bachurin SO, Richardson RJ (2016) <br />Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo<br /><i>Chemico-Biological Interactions</i> <b>259</b>: 332<br /><br />Masson P, Lushchekina SV (2016) <br />Emergence of catalytic bioscavengers against organophosphorus agents<br /><i>Chemico-Biological Interactions</i> <b>259</b>: 319<br /><br />Boltneva NP, Makhaeva GF, Kovaleva NV, Lushchekina SV, Burgart YV, Shchegol'kov EV, Saloutin VI, Chupakhin ON (2015) <br />Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase<br /><i>Dokl Biochem Biophys</i> <b>465</b>: 381<br /><br />Lushchekina SV, Delacour H, Lockridge O, Masson P (2015) <br />Human butyrylcholinesterase polymorphism: Molecular modeling<br /><i>Int J Risk Saf Med</i> <b>27 Suppl 1</b>: S80<br /><br />Lushchekina SV, Kots ED, Kharlamova AD, Petrov KA, Masson P (2015) <br />Molecular modeling of mechanism of action of anti-myasthenia gravis slow-binding inhibitor of acetylcholinesterase<br /><i>Int J Risk Saf Med</i> <b>27 Suppl 1</b>: S74<br /><br />Makhaeva GF, Lushchekina SV, Boltneva NP, Sokolov VB, Grigoriev VV, Serebryakova OG, Vikhareva EA, Aksinenko AY, Barreto GE, Aliev G, Bachurin SO (2015) <br />Conjugates of gamma-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease<br /><i>Sci Rep</i> <b>5</b>: 13164<br /><br />Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015) <br />6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease<br /><i>ChemMedChem</i> <b>10</b>: 1863<br /><br />Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015) <br />6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease<br /><i>Int J Risk Saf Med</i> <b>27 Suppl 1</b>: S69<br /><br />Delacour H, Lushchekina SV, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, Lockridge O, Masson P (2014) <br />Characterization of a Novel BCHE Silent Allele: Point Mutation (p.Val204Asp) Causes Loss of Activity and Prolonged Apnea with Suxamethonium<br /><i>PLoS ONE</i> <b>9</b>: e101552<br /><br />Delacour H, Lushchekina SV, Mabboux I, Ceppa F, Masson P, Schopfer LM, Lockridge O (2014) <br />Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), silent with mivacurium<br /><i>Biochemical Pharmacology</i> <b>92</b>: 476<br /><br />Lushchekina SV, Nemukhin AV, Varfolomeev SD, Masson P (2014) <br />Molecular Modeling Evidence for His438 Flip in the Mechanism of Butyrylcholinesterase Hysteretic Behavior<br /><i>Journal of Molecular Neuroscience</i> <b>52</b>: 434<br /><br />Lushchekina SV, Masson P, Rosenberry TL (2013) <br />This special Issue of Chemico-Biological Interactions comprises 70 manuscripts from lectures and short talks given at the 11th International Meeting on Cholinesterases. Preface<br /><i>Chemico-Biological Interactions</i> <b>203</b>: 1<br /><br />Makhaeva GF, Lushchekina SV, Serebryakova OG, Aksinenko AY, Goreva TV, Richardson RJ, Martynov IV (2013) <br />Kinetics and mechanism of inhibition of serine esterases by fluorinated carbethoxy 1-aminophosphonates<br /><i>Dokl Biochem Biophys</i> <b>451</b>: 203<br /><br />Masson P, Lushchekina SV, Schopfer LM, Lockridge O (2013) <br />Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies<br /><i>Biochemical Journal</i> <b>454</b>: 387<br /><br />Nemukhin AV, Grigorenko BL, Morozov DI, Kochetov MS, Lushchekina SV, Varfolomeev SD (2013) <br />On quantum mechanical - molecular mechanical (QM/MM) approaches to model hydrolysis of acetylcholine by acetylcholinesterase<br /><i>Chemico-Biological Interactions</i> <b>203</b>: 51<br /><br />Rozengart EV, Basova NE, Moralev SN, Lushchekina SV, Masson P, Varfolomeev SD (2013) <br />Research on cholinesterases in the Soviet Union and Russia: a historical perspective<br /><i>Chemico-Biological Interactions</i> <b>203</b>: 3<br /><br />Lushchekina SV, Nemukhin AV, Morozov DI, Varfolomeev SD (2010) <br />Correlation between the substrate structure and the rate of acetylcholinesterase hydrolysis modeled with the combined quantum mechanical/molecular mechanical studies<br /><i>Chemico-Biological Interactions</i> <b>187</b>: 59<br /><br />Nemukhin AV, Lushchekina SV, Bochenkova AV, Golubeva AA, Varfolomeev SD (2008) <br />Characterization of a complete cycle of acetylcholinesterase catalysis by ab initio QM/MM modeling<br /><i>J Mol Model</i> <b>14</b>: 409<br /><br />